TuisSRT3 • FRA
add
Sartorius AG Preference Shares
Vorige sluiting
€192,90
Dagwisseling
€191,30 - €195,80
Jaarwisseling
€169,45 - €291,60
Markkapitalisasie
13,36 mjd EUR
Gemiddelde volume
254,00
P/V-verhouding
129,06
Dividend-opbrengs
0,37%
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (EUR) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 884,30 m | 2,74% |
Bedryfskoste | 284,30 m | 0,82% |
Netto inkomste | 32,50 m | 35,42% |
Netto winsgrens | 3,68 | 31,90% |
Wins per aandeel | 1,22 | 7,02% |
EBITDA | 234,40 m | 13,51% |
Effektiewe belastingkoers | 26,94% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (EUR) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 819,00 m | 30,96% |
Totale bates | 10,03 mjd | 0,85% |
Totale aanspreeklikheid | 6,23 mjd | 1,64% |
Totale ekwiteit | 3,79 mjd | — |
Uitstaande aandele | — | — |
Prys om te bespreek | — | — |
Opbrengs op bates | 3,27% | — |
Opbrengs op kapitaal | 3,90% | — |
Kontantvloei
Netto kontantverandering
| (EUR) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 32,50 m | 35,42% |
Kontant van bedrywe | 150,20 m | -50,17% |
Kontant van beleggings | -89,50 m | 13,61% |
Kontant van finansiering | -77,90 m | 89,01% |
Netto kontantverandering | -20,60 m | 95,97% |
Beskikbare kontantvloei | -23,64 m | -124,83% |
Meer oor
Sartorius AG is an international pharmaceutical and laboratory equipment supplier. In September 2021, Sartorius was admitted to the DAX, Germany's largest stock market index. Sartorius supports its customers in the development and production of biotech drugs and vaccines. The company has two major divisions: Bioprocess Solutions and Lab Products & Services. Wikipedia
Gestig
1870
Webwerf
Werknemers
13 685
